New Amsterdam Partners LLC NY boosted its stake in shares of Masimo Corporation (NASDAQ:MASI) by 17.9% during the second quarter, Holdings Channel reports. The fund owned 73,530 shares of the medical equipment provider’s stock after buying an additional 11,147 shares during the period. Masimo Corporation comprises approximately 1.4% of New Amsterdam Partners LLC NY’s investment portfolio, making the stock its 27th largest position. New Amsterdam Partners LLC NY’s holdings in Masimo Corporation were worth $6,704,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Shell Asset Management Co. purchased a new position in shares of Masimo Corporation during the first quarter valued at about $1,081,000. Cardinal Capital Management increased its position in shares of Masimo Corporation by 0.9% in the first quarter. Cardinal Capital Management now owns 23,481 shares of the medical equipment provider’s stock valued at $2,190,000 after buying an additional 198 shares during the last quarter. Dubuque Bank & Trust Co. purchased a new position in shares of Masimo Corporation during the first quarter valued at about $169,000. Glen Harbor Capital Management LLC increased its position in shares of Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 110 shares during the last quarter. Finally, First Citizens Bank & Trust Co. purchased a new position in shares of Masimo Corporation during the first quarter valued at about $266,000. 84.39% of the stock is currently owned by institutional investors and hedge funds.

Shares of Masimo Corporation (NASDAQ MASI) opened at 83.58 on Friday. The firm has a market capitalization of $4.34 billion, a price-to-earnings ratio of 13.70 and a beta of 0.80. The company’s 50-day moving average is $92.27 and its 200-day moving average is $89.85. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million for the quarter, compared to analyst estimates of $189.03 million. During the same quarter last year, the firm posted $0.57 earnings per share. The company’s quarterly revenue was up 11.8% compared to the same quarter last year. On average, equities analysts forecast that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Masimo Corporation (NASDAQ:MASI) Position Raised by New Amsterdam Partners LLC NY” was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/12/masimo-corporation-nasdaqmasi-position-raised-by-new-amsterdam-partners-llc-ny.html.

Several equities analysts recently issued reports on the stock. Roth Capital upped their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. BidaskClub downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Stifel Nicolaus assumed coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price objective on the stock. Finally, Wedbush reissued an “outperform” rating and set a $112.00 price objective on shares of Masimo Corporation in a research note on Monday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $94.00.

In other news, insider Rick Fishel sold 15,000 shares of Masimo Corporation stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $94.85, for a total value of $1,422,750.00. Following the transaction, the insider now owns 35,022 shares of the company’s stock, valued at $3,321,836.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Jon Coleman sold 25,000 shares of Masimo Corporation stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now directly owns 32,201 shares in the company, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. In the last three months, insiders sold 115,000 shares of company stock worth $10,773,180. Insiders own 16.60% of the company’s stock.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.